Marker Therapeutics, Inc.MRKRNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-11.8%
5Y CAGR-11.4%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-11.8%/yr
vs -37.0%/yr prior
5Y CAGR
-11.4%/yr
Consistent
Acceleration
+25.2pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$15.98M-9.7%
2024$17.71M-1.0%
2023$17.89M-23.2%
2022$23.30M-42.8%
2021$40.72M+38.7%
2020$29.35M+29.1%
2019$22.74M-84.7%
2018$148.38M+1192.5%
2017$11.48M+39.0%
2016$8.26M-